Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 813-944-0 | CAS number: 1884575-91-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Acute Toxicity: oral
Administrative data
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- February 22, 2016 - May 11, 2016
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- test procedure in accordance with generally accepted scientific standards and described in sufficient detail
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 2 016
- Report date:
- 2016
Materials and methods
Test guideline
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 423 (Acute Oral toxicity - Acute Toxic Class Method)
- Deviations:
- no
- GLP compliance:
- yes (incl. QA statement)
- Test type:
- acute toxic class method
- Limit test:
- no
Test material
- Reference substance name:
- N,N'-bis{N-[N-(4-chlorophenyl)carbamimidoyl]carbamimidoyl}hexane-1,6-bis(aminium) diundec-10-enoate
- EC Number:
- 813-944-0
- Cas Number:
- 1884575-91-0
- Molecular formula:
- C44H70Cl2N10O4
- IUPAC Name:
- N,N'-bis{N-[N-(4-chlorophenyl)carbamimidoyl]carbamimidoyl}hexane-1,6-bis(aminium) diundec-10-enoate
- Test material form:
- solid: particulate/powder
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Batch No.of test material: 001/CHUA/01 16
- Expiration date of the lot/batch: December 2017
- Purity test date: January 2016
Test animals
- Species:
- rat
- Strain:
- Wistar
- Sex:
- female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Animal breeding, RCC laboratories India Private Limited
- Females nulliparous and non-pregnant: [yes]
- Age at study initiation: 9-12 weeks
- Weight at study initiation: Females 158.3 to 206.1 g
- Fasting period before study: fasted overnight
- Housing:
- Diet (e.g. ad libitum):
- Water (e.g. ad libitum):
- Acclimation period: Under laboratory conditions for 7, 12, 15 and 8 days for Step I, Step II, Step III and Step IV, respectively after veterinary observation. Only animals without any visible signs of illness were used for the study.
ENVIRONMENTAL CONDITIONS
- Temperature (°C):
- Humidity (%):
- Air changes (per hr):
- Photoperiod (hrs dark / hrs light):
IN-LIFE DATES: From: To:
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- peanut oil
- Details on oral exposure:
- VEHICLE
- Concentration in vehicle: 300 mg and 2000 mg
- Amount of vehicle (if gavage): 10 mL
- Justification for choice of vehicle: Refined groundnut oil was selected as vehicle based on preliminary solubility testing which was
performed at the test facility before the study initiation date.
MAXIMUM DOSE VOLUME APPLIED: 10 mL/kg body weight
DOSAGE PREPARATION : The dose levels were in terms of the test item as supplied by the sponsor. The dose formulations were prepared shortly before each dosing. The test item (300 mg for Step I, II and 2000 mg for Step III, Step IV) was weighed into a pre-weighed glass beaker on a Sartorius balance. The test item was transferred to a mortar and triturated with pestle. Three mL of the vehicle was added to mortar and again triturated. 2 ml of vehicle was used twice to rinse the mortar and pestle. This was then transferred to a 10 mL volumetric flask. Sufficient quantity of vehicle was added to make up the required volume of suspension (w/v) to 10 mL. This was then transferred back to the beaker and mixed properly. The test item formed suspension in refined ground nut oil. Homogeneity of the test item in the vehicle was maintained during administration using a magnetic
stirrer.
CLASS METHOD (if applicable)
- Rationale for the selection of the starting dose: - Doses:
- 300 mg/kg body weight and 2000 mg/kg body weight
- No. of animals per sex per dose:
- Three animals / dose
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: daily
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: mortality, viability, clinical signs - Statistics:
- No statistics
Results and discussion
Effect levels
- Key result
- Sex:
- female
- Dose descriptor:
- LD50
- Effect level:
- 5 000 mg/kg bw
- Based on:
- test mat.
- Mortality:
- No mortality
- Clinical signs:
- other: No clinical signs
- Gross pathology:
- No abnormalities were observed in any of the treated animals of Step I (Animal No. 02, ;)~;; and Step II
(Animal No. 04, 05, 06) except Animal No. 01 revealed incidental finding on uterus which was
distended with watery content Moderately during necropsy at terminal sacrifice.
No abnormalities were observed in any of the 'Teated animals of Step III (Animal No 'Step N (Animal No. 10, 11, 12). - Other findings:
- - Organ weights:
- Histopathology:
- Potential target organs:
- Other observations:
Any other information on results incl. tables
No mortalities were observed in any of the treated animals dosed at 300 and 2000 mg/kg body weight in Steps I, II, III and IV.
All the animals were normal throughout the acclimatization period. All the treated animals at 300 (Step I and Step II) and 2000 (Step III and Step IV) mg/kg body weight were found to be normal at approximately 30 minutes, at 1, 2, 3 and 4 hours observation an day 0 post
test item administration till the last day of observation period {day 14).
All the animals of Step I, Step II, Step III and Step IV had gained body weight by days 7 and 14 compared to day 0
Ne abnormalities were observed in any of the treated animals of Step I (Animal No. 02, 03) and Step II
(Animal No. 04, 05, 06) except Animal No. 01 revealed incidental finding on uterus which was distended with watery content Moderately during necropsy at terminal sacrifice. No abnormalities were observed in any of the 'treated animals of Step III (Animal No 07, 08, 09) and Step N (Animal No. 10, 11, 12).
Applicant's summary and conclusion
- Interpretation of results:
- Category 5 based on GHS criteria
- Conclusions:
- LD50 (cut off value): 5000 mg/kg body weight and is classified as category 5 or unclassified.
LD50 greater than 2000 mg/kg body weight. - Executive summary:
Four groups, each of three female Wistar rats, fasted overnight, were treated with CHUA by oral gavage administration at a dosage of 300 mg/kg body weight for Step I, II and 2000 mg/kg body weight for Step III, IV. The test item was formulated in vehicle (Refined groundnut oil) at a concentration of 30mg/mL (Step I, II) and 200 mg/mL (Step III, IV). The test item was administered at a dose volume of 10mL/kg body weight.
The animals were observed daily during the acclimatization period and mortality/viability and clinical signs were recorded. All the animals were observed for clinical signs during first 30 minutes and at approximately 1, 2, 3 and 4 hours post test item administration on test day 0 and once daily during test days 1-14. Mortality/viability was recorded during first 30 minutes and at approximately 1, 2, 3 and 4 hours post test item administration on test day 0 (in common with the clinical signs) and twice daily during days l-14 (once on day of sacrifice). Body weights were recorded on test days 0 (prior to test item administration), 7 and 14. All the animals were necropsied and examined macroscopically at the end of observation period.
The animals were treated as follows:
- Step I 3 females treated at 300 mg/kg, Mortality '0 out of 3'
- Step II 3 females treated at 300 mg/kg, Mortality '0 out of 3'
- Step III 3 females treated at 2000 mg/kg, Mortality '0 out of 3'
- Step IV 3 females treated at 2000 mg/kg, Mortality '0 out of 3'
All the animals appeared normal throughout the acclimatization period. No mortalities were observed in any of the treated animals dosed at 300 and 2000 mg/kg body weight in Steps I, II, III and IV.
All the treated animals at 300 (Step I and Step II) and 2000 (Step III and Step IV) mg/kg body weight were found to be normal at approximately 30 minutes, at 1, 2, 3 and 4 hours observation on day 0 post test item administration till the last day of observation period (day 14).
All the surviving animals of Step I, II, III and IV had gained body weight by days 7 and 14 compared to day 0.
No abnormalities were observed in any of the treated animals of Step I (Animal No. 02, 03) and Step II (Animal No. 04, 0'5, 06) except Animal No. 01 revealed incidental finding on uterus which was distended with watery content moderately during necropsy at terminal sacrifice.
No abnormalities were observed in any of the treated animals of Step III (Animal No. 07, 08, 09) and Step IV (Animal No. 10, 11, 12).
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.